Literature DB >> 2591346

Hemimegalencephaly and intractable epilepsy: benefits of hemispherectomy.

F Vigevano1, E Bertini, R Boldrini, C Bosman, D Claps, M di Capua, C di Rocco, G F Rossi.   

Abstract

We observed 4 children with hemimegalencephaly, (3 boys, 1 girl aged 3-7 years). One child had a linear sebaceous nevus. All patients had a similar clinical, EEG, and neuroradiologic pattern. All patients had macrocrania, hemiparesis, hemianopsia, and psychomotor retardation of variable degree. All cases had an epileptic syndrome with onset during the first days or the first months of life. The seizures were consistently similar: partial motor seizures, generally hemiclonic and asymmetric brief tonic seizures, in series, involving predominantly one side of the body, contralateral to the cerebral damage. The EEG was initially characterized by a hemihypsarrhythmia and afterward, over the malformed hemisphere, by a rather high-frequency background activity associated with almost continuous transients of spikes, sharp waves, and spike and waves that progressively involved the contralateral hemisphere. Hemispherectomy was performed in two children with sudden and complete recovery from seizures and improvement in psychomotor development. Macroscopic examination was consistent with the computed tomography (CT) scan and magnetic resonance imaging (MRI) showing pachygyria and poorly represented white matter. Histologic examination showed the characteristic absence of cortical neuronal layering, and the presence of giant neurons, neuronal heterotopias, and gliosis. For hemispherectomy to be successful, we believe prolonged EEG monitoring is needed to verify that no seizures are originating in the normal hemisphere.

Entities:  

Mesh:

Year:  1989        PMID: 2591346     DOI: 10.1111/j.1528-1157.1989.tb05347.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Epilepsy and Cortical Dysplasias.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-11       Impact factor: 3.598

2.  Neuropathologic findings in surgically treated hemimegalencephaly: immunohistochemical, morphometric, and ultrastructural study.

Authors:  M J De Rosa; D L Secor; M Barsom; R S Fisher; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Hemimegalencephaly: clinical implications and surgical treatment.

Authors:  C Di Rocco; D Battaglia; D Pietrini; M Piastra; L Massimi
Journal:  Childs Nerv Syst       Date:  2006-07-05       Impact factor: 1.475

Review 4.  Diffusion tensor imaging and fiber tractography in brain malformations.

Authors:  Andrea Poretti; Avner Meoded; Andrea Rossi; Charles Raybaud; Thierry A G M Huisman
Journal:  Pediatr Radiol       Date:  2013-01-04

Review 5.  Epilepsy in the pediatric age and its surgical treatment.

Authors:  G F Rossi
Journal:  Childs Nerv Syst       Date:  1995-01       Impact factor: 1.475

Review 6.  Surgery for posterior quadrantic cortical dysplasia. A review.

Authors:  G Tamburrini; D Battaglia; E Albamonte; I Contaldo; L Massimi; M Caldarelli; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2014-10-09       Impact factor: 1.475

Review 7.  Hemimegalencephaly without epilepsy: case report.

Authors:  Greg James; Mano Shanmuganathan; William Harkness
Journal:  Childs Nerv Syst       Date:  2014-03-04       Impact factor: 1.475

8.  Longitudinal CT and MR appearances of hemimegalencephaly in a patient with tuberous sclerosis.

Authors:  Ravikanth Balaji; Chandrasekharan Kesavadas; K Ramachandran; S Dinesh Nayak; T Priyakumari
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

9.  Reversible operculum syndrome caused by progressive epilepsia partialis continua in a child with left hemimegalencephaly.

Authors:  L Fusco; F Vigevano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

10.  Hemimegalencephaly and normal intellectual development.

Authors:  L Fusco; S Ferracuti; G Fariello; M Manfredi; F Vigevano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.